TCL1: A new drug target in lymphoid and germ-cell malignancies?

International Journal of Biochemistry and Cell Biology

Volumn 35, Issue 12, 2003, Pages 1614-1618

  Lock, Richard B ^a  

^a CHILDREN S CANCER INSTITUTE AUSTRALIA FOR MEDICAL RESEARCH   (Australia)

Author keywords

Akt; Cancer; TCL1

Indexed keywords

COMPLEMENTARY DNA; DNA FRAGMENT; ENZYME ACTIVATOR; NUCLEOTIDE; ONCOPROTEIN; PROTEIN KINASE B; RNA; T CELL LEUKEMIA LYMPHOMA 1 ONCOPROTEIN; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ARTICLE; DRUG TARGETING; ENZYME ACTIVATION; GENE EXPRESSION; GENE STRUCTURE; GERM CELL TUMOR; HUMAN; LYMPHATIC SYSTEM TUMOR; NONHUMAN; ONCOGENE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS;

EID: 0142092763     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(03)00146-8     Document Type: Short Survey

References (16)

1. Bichi R., Shinton S.A., Martin E.S., Koval A., Calin G.A., Cesari R., Russo G., Hardy R.R., Croce C.M. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proceedings of the National Academy of Sciences of the United States of America. 99:2002;6955-6960.
2. Brazil D.P., Hemmings B.A. Ten years of protein kinase B signalling: A hard Akt to follow. Trends in Biochemical Sciences. 26:2001;657-664.
3. French S.W., Shen R.R., Koh P.J., Malone C.S., Mallick P., Teitell M.A. A modeled hydrophobic domain on the TCL1 oncoprotein mediates association with AKT at the cytoplasmic membrane. Biochemistry. 41:2002;6376-6382.
4. Hoh F., Yang Y.S., Guignard L., Padilla A., Stern M.H., Lhoste J.M., van Tilbeurgh H. Crystal structure of p14TCL1, an oncogene product involved in T-cell prolymphocytic leukemia, reveals a novel beta-barrel topology. Structure. 6:1998;147-155.
5. Hoyer K.H., French S.W., Turner D.E., Nguyen M.T.N., Renard M., Malone C.S., Knoetig S., Qi C.-F., Su T.T., Cheroutre H., Wall R., Rawlings D.J., Morse H.C. III, Teitell M.A. Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America. 99:2002;14392-14397.
6. Kunstle G., Laine J., Pierron G., Kagami S.-I., Nakajima H., Hoh F., Roumestand C., Stern M.-H., Noguchi M. Identification of Akt association and oligomerization domains of the Akt kinase coactivator TCL1. Molecular and Cellular Biology. 22:2002;1513-1525.
7. Laine J., Kunstle G., Obata T., Noguchi M. Differential regulation of Akt kinase isoforms by members of the TCL1 oncogene family. The Journal of Biological Chemistry. 277:2002;3743-3751.
8. Laine J., Kunstle G., Obata T., Sha M., Noguchi M. The protooncogene TCL1 is an Akt kinase coactivator. Molecular Cell. 6:2000;395-407.
9. Narducci M.G., Fiorenza M.T., Kang S.-M., Bevilacqua A., Di Giacomo M., Remotti D., Picchio M.C., Fidanza V., Cooper M.D., Croce C.M., Mangia F., Russo G. TCL1 participates in early embryonic development and is overexpressed in human seminomas. Proceedings of the National Academy of Sciences of the United States of America. 99:2002;11712-11717.
10. Narducci M.G., Pescarmona E., Lazzeri C., Signoretti S., Lavinia A.M., Remotti D., Scala E., Baroni C.D., Stoppacciaro A., Croce C.M., Russo G. Regulation of TCL1 expression in B- and T-cell lymphomas and reactive lymphoid tissue. Cancer Research. 60:2000;2095-2100.
11. Pekarsky Y., Hallas C., Isobe M., Russo G., Croce C.M. Abnormalities at 14q32.1 in T cell malignancies involve two oncogenes. Proceedings of the National Academy of Sciences of the United States of America. 96:1999;2949-2951.
12. Pekarsky Y., Koval A., Hallas C., Bichi R., Tresini M., Malstrom S., Russo G., Tsichlis P., Croce C.M. Tcl1 enhances Akt kinase activity and mediates its nuclear translocation. Proceedings of the National Academy of Sciences of the United States of America. 97:2000;3028-3033.
13. Petock J.M., Torshin I.Y., Wang Y.F., Du Bois G.C., Croce C.M., Harrison R.W., Weber I.T. Structure of murine Tcl1 at 2.5 Å resolution and implications for the TCL oncogene family. Acta Crystallographica. 57:2001;1545-1551.
14. Virgilio L., Lazzeri C., Bichi R., Nibu K.-I., Narducci M.G., Russo G., Rothstein J.L., Croce C.M. Deregulated expression of TCL1 causes T cell leukemia in mice. Proceedings of the National Academy of Sciences of the United States of America. 95:1998;3885-3889.
15. Virgilio L., Narducci M.G., Isobe M., Billips L.G., Cooper M.D., Croce C.M., Russo G. Identification of the TCL1 gene involved in T-cell malignancies. Proceedings of the National Academy of Sciences of the United States of America. 91:1994;12530-12534.
16. Yuille M.R., Condie A., Stone E.M., Wilsher J., Bradshaw P.S., Brooks L., Catovsky D. TCL1 is activated by chromosomal rearrangement or by hypomethylation. Genes, Chromosomes and Cancer. 30:2001;336-341.